{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T08:58:31Z","timestamp":1776329911686,"version":"3.50.1"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T00:00:00Z","timestamp":1773014400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T00:00:00Z","timestamp":1776297600000},"content-version":"vor","delay-in-days":38,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82260593"],"award-info":[{"award-number":["82260593"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82260552"],"award-info":[{"award-number":["82260552"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Guangxi science and technology project","award":["AA21196004"],"award-info":[{"award-number":["AA21196004"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Cell Int"],"DOI":"10.1186\/s12935-026-04251-0","type":"journal-article","created":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T11:16:28Z","timestamp":1773054988000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["PAARH suppresses Kupffer cell phagocytosis to promote tumor liver metastasis by upregulating CD47"],"prefix":"10.1186","volume":"26","author":[{"given":"Wenchuan","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunyu","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rongzhou","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaoxiong","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianzhe","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiajie","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuan","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huamei","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhongheng","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Pu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,9]]},"reference":[{"issue":"8","key":"4251_CR1","first-page":"1564","volume":"186","author":"S Gerstberger","year":"2023","unstructured":"Gerstberger S, Jiang Q, Ganesh K. Metastasis Cell. 2023;186(8):1564\u201379.","journal-title":"Metastasis Cell"},{"issue":"1","key":"4251_CR2","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s41572-021-00261-6","volume":"7","author":"DI Tsilimigras","year":"2021","unstructured":"Tsilimigras DI, Brodt P, Clavien PA, Muschel RJ, D\u2019Angelica MI, Endo I, et al. Liver metastases. Nat Rev Dis Primers. 2021;7(1):27.","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"4251_CR3","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1007\/s00018-025-05651-7","volume":"82","author":"L Li","year":"2025","unstructured":"Li L, Xu L, Liao W, Wang P, Xu M, Li B, et al. circCEP70 encoded protein inhibits the progression of hepatocellular carcinoma. Cell Mol Life Sci. 2025;82(1):174.","journal-title":"Cell Mol Life Sci"},{"issue":"2","key":"4251_CR4","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.jhep.2016.09.021","volume":"66","author":"M Furuta","year":"2017","unstructured":"Furuta M, Ueno M, Fujimoto A, Hayami S, Yasukawa S, Kojima F, et al. Whole genome sequencing discriminates hepatocellular carcinoma with intrahepatic metastasis from multi-centric tumors. J Hepatol. 2017;66(2):363\u201373.","journal-title":"J Hepatol"},{"issue":"17","key":"4251_CR5","doi-asserted-by":"publisher","first-page":"3292","DOI":"10.1158\/0008-5472.CAN-24-4784","volume":"85","author":"YD Wu","year":"2025","unstructured":"Wu YD, Huang XX, Zhang HX, Pan Y, Xie CK, Li G, et al. TRAF3IP2-AS1 Deficiency Induces Necroptosis to Promote Pancreatic Cancer Liver Metastasis. Cancer Res. 2025;85(17):3292\u2013312.","journal-title":"Cancer Res"},{"issue":"1","key":"4251_CR6","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1038\/s41467-023-36521-0","volume":"14","author":"Q Li","year":"2023","unstructured":"Li Q, Zhang XX, Hu LP, Ni B, Li DX, Wang X, et al. Coadaptation fostered by the SLIT2-ROBO1 axis facilitates liver metastasis of pancreatic ductal adenocarcinoma. Nat Commun. 2023;14(1):861.","journal-title":"Nat Commun"},{"key":"4251_CR7","doi-asserted-by":"crossref","unstructured":"Mielgo A, Schmid MC. Liver Tropism in Cancer: The Hepatic Metastatic Niche. Cold Spring Harb Perspect Med. 2020;10(3):a037259.","DOI":"10.1101\/cshperspect.a037259"},{"issue":"9","key":"4251_CR8","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.1038\/s12276-024-01303-1","volume":"56","author":"A Shaha","year":"2024","unstructured":"Shaha A, Wang Y, Wang X, Wang D, Guinovart D, Liu B, et al. CMTM6 mediates the Warburg effect and promotes the liver metastasis of colorectal cancer. Exp Mol Med. 2024;56(9):2002\u201315.","journal-title":"Exp Mol Med"},{"key":"4251_CR9","doi-asserted-by":"crossref","unstructured":"Xu W, Xu J, Liu J, Wang N, Zhou L, Guo J. Liver Metastasis in Cancer: Molecular Mechanisms and Management. MedComm (2020). 2025;6(3):e70119.","DOI":"10.1002\/mco2.70119"},{"issue":"9","key":"4251_CR10","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/s41568-021-00383-9","volume":"21","author":"X Li","year":"2021","unstructured":"Li X, Ramadori P, Pfister D, Seehawer M, Zender L, Heikenwalder M. The immunological and metabolic landscape in primary and metastatic liver cancer. Nat Rev Cancer. 2021;21(9):541\u201357.","journal-title":"Nat Rev Cancer"},{"issue":"11","key":"4251_CR11","doi-asserted-by":"publisher","first-page":"2517","DOI":"10.1038\/s12276-025-01573-3","volume":"57","author":"Y Deng","year":"2025","unstructured":"Deng Y, Guo C, Liu X, Li X, Liu J, Liu W, et al. Single-cell transcriptomic profiling reveals liver fibrosis in colorectal cancer liver metastasis. Exp Mol Med. 2025;57(11):2517\u201332.","journal-title":"Exp Mol Med"},{"issue":"1","key":"4251_CR12","doi-asserted-by":"publisher","first-page":"6330","DOI":"10.1038\/s41467-023-41771-z","volume":"14","author":"SK Thomas","year":"2023","unstructured":"Thomas SK, Wattenberg MM, Choi-Bose S, Uhlik M, Harrison B, Coho H, et al. Kupffer cells prevent pancreatic ductal adenocarcinoma metastasis to the liver in mice. Nat Commun. 2023;14(1):6330.","journal-title":"Nat Commun"},{"issue":"1","key":"4251_CR13","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1007\/s00018-024-05451-5","volume":"82","author":"H Lin","year":"2024","unstructured":"Lin H, Wieser A, Zhang J, Regel I, Niess H, Mayerle J, et al. Gram-negative bacteria-driven increase of cytosolic phospholipase A2 leads to activation of Kupffer cells. Cell Mol Life Sci. 2024;82(1):22.","journal-title":"Cell Mol Life Sci"},{"issue":"8000","key":"4251_CR14","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1038\/s41586-023-06950-4","volume":"626","author":"Z Deng","year":"2024","unstructured":"Deng Z, Loyher PL, Lazarov T, Li L, Shen Z, Bhinder B, et al. The nuclear factor ID3 endows macrophages with a potent anti-tumour activity. Nature. 2024;626(8000):864\u201373.","journal-title":"Nature"},{"issue":"11","key":"4251_CR15","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1038\/s41590-023-01634-7","volume":"24","author":"J Li","year":"2023","unstructured":"Li J, Liu XG, Ge RL, Yin YP, Liu YD, Lu WP, et al. The ligation between ERMAP, galectin-9 and dectin-2 promotes Kupffer cell phagocytosis and antitumor immunity. Nat Immunol. 2023;24(11):1813\u201324.","journal-title":"Nat Immunol"},{"issue":"1","key":"4251_CR16","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s00018-025-05700-1","volume":"82","author":"WP Lu","year":"2025","unstructured":"Lu WP, Liu YD, Zhang ZF, Liu J, Ye JW, Wang SY, et al. m(6)A-modified MIR670HG suppresses tumor liver metastasis through enhancing Kupffer cell phagocytosis. Cell Mol Life Sci. 2025;82(1):185.","journal-title":"Cell Mol Life Sci"},{"issue":"2","key":"4251_CR17","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/s41419-022-04505-5","volume":"13","author":"H Wei","year":"2022","unstructured":"Wei H, Xu Z, Chen L, Wei Q, Huang Z, Liu G, et al. Long non-coding RNA PAARH promotes hepatocellular carcinoma progression and angiogenesis via upregulating HOTTIP and activating HIF-1alpha\/VEGF signaling. Cell Death Dis. 2022;13(2):102.","journal-title":"Cell Death Dis"},{"issue":"2","key":"4251_CR18","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cell.2009.05.046","volume":"138","author":"S Jaiswal","year":"2009","unstructured":"Jaiswal S, Jamieson CH, Pang WW, Park CY, Chao MP, Majeti R, et al. CD47 is upregulated on circulating hematopoietic stem cells and leukemia cells to avoid phagocytosis. Cell. 2009;138(2):271\u201385.","journal-title":"Cell"},{"issue":"49","key":"4251_CR19","doi-asserted-by":"publisher","first-page":"14097","DOI":"10.1073\/pnas.1617903113","volume":"113","author":"Y Kimura","year":"2016","unstructured":"Kimura Y, Inoue A, Hangai S, Saijo S, Negishi H, Nishio J, et al. The innate immune receptor Dectin-2 mediates the phagocytosis of cancer cells by Kupffer cells for the suppression of liver metastasis. Proc Natl Acad Sci U S A. 2016;113(49):14097\u2013102.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"45","key":"4251_CR20","doi-asserted-by":"publisher","first-page":"E6215","DOI":"10.1073\/pnas.1520032112","volume":"112","author":"H Zhang","year":"2015","unstructured":"Zhang H, Lu H, Xiang L, Bullen JW, Zhang C, Samanta D, et al. HIF-1 regulates CD47 expression in breast cancer cells to promote evasion of phagocytosis and maintenance of cancer stem cells. Proc Natl Acad Sci U S A. 2015;112(45):E6215\u201323.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"13","key":"4251_CR21","doi-asserted-by":"publisher","first-page":"3281","DOI":"10.7150\/ijbs.60782","volume":"17","author":"X Jia","year":"2021","unstructured":"Jia X, Yan B, Tian X, Liu Q, Jin J, Shi J, et al. CD47\/SIRPalpha pathway mediates cancer immune escape and immunotherapy. Int J Biol Sci. 2021;17(13):3281\u20137.","journal-title":"Int J Biol Sci"},{"issue":"4","key":"4251_CR22","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.cmet.2015.08.007","volume":"22","author":"F Dupuy","year":"2015","unstructured":"Dupuy F, Tabaries S, Andrzejewski S, Dong Z, Blagih J, Annis MG, et al. PDK1-Dependent Metabolic Reprogramming Dictates Metastatic Potential in Breast Cancer. Cell Metab. 2015;22(4):577\u201389.","journal-title":"Cell Metab"},{"issue":"12","key":"4251_CR23","doi-asserted-by":"publisher","first-page":"2489","DOI":"10.1158\/2159-8290.CD-23-1323","volume":"14","author":"N Yamaguchi","year":"2024","unstructured":"Yamaguchi N, Wu YG, Ravetch E, Takahashi M, Khan AG, Hayashi A, et al. A Targetable Secreted Neural Protein Drives Pancreatic Cancer Metastatic Colonization and HIF1alpha Nuclear Retention. Cancer Discov. 2024;14(12):2489\u2013508.","journal-title":"Cancer Discov"},{"issue":"2","key":"4251_CR24","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1002\/hep.510310201","volume":"31","author":"K Jungermann","year":"2000","unstructured":"Jungermann K, Kietzmann T. Oxygen: modulator of metabolic zonation and disease of the liver. Hepatology. 2000;31(2):255\u201360.","journal-title":"Hepatology"},{"issue":"3","key":"4251_CR25","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.ccell.2018.02.001","volume":"33","author":"T Schild","year":"2018","unstructured":"Schild T, Low V, Blenis J, Gomes AP. Unique Metabolic Adaptations Dictate Distal Organ-Specific Metastatic Colonization. Cancer Cell. 2018;33(3):347\u201354.","journal-title":"Cancer Cell"},{"key":"4251_CR26","doi-asserted-by":"crossref","unstructured":"Sun Z, Zhou M, Song N, Wang C, Liu M, He S et al. SKA3-mediated hypoxia tolerance and metabolic reprogramming promote liver metastasis in lung adenocarcinoma. Cell Death Dis. 2025;17(1):65.","DOI":"10.1038\/s41419-025-08270-z"},{"issue":"26","key":"4251_CR27","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.1056\/NEJMoa1200690","volume":"366","author":"SL Topalian","year":"2012","unstructured":"Topalian SL, Hodi FS, Brahmer JR, Gettinger SN, Smith DC, McDermott DF, et al. Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. N Engl J Med. 2012;366(26):2443\u201354.","journal-title":"N Engl J Med"},{"issue":"4","key":"4251_CR28","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.cell.2017.01.016","volume":"168","author":"WA Lim","year":"2017","unstructured":"Lim WA, June CH. The Principles of Engineering Immune Cells to Treat Cancer. Cell. 2017;168(4):724\u201340.","journal-title":"Cell"},{"issue":"12","key":"4251_CR29","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1038\/s41590-024-02015-4","volume":"25","author":"S Goswami","year":"2024","unstructured":"Goswami S, Pauken KE, Wang L, Sharma P. Next-generation combination approaches for immune checkpoint therapy. Nat Immunol. 2024;25(12):2186\u201399.","journal-title":"Nat Immunol"},{"issue":"1","key":"4251_CR30","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/s41590-024-02027-0","volume":"26","author":"Z Zhang","year":"2025","unstructured":"Zhang Z, Langenbach M, Sagar S, Fetsch V, Stritzker J, Severa E, et al. Efficacy of CTLA-4 checkpoint therapy is dependent on IL-21 signaling to mediate cytotoxic reprogramming of PD-1(+)CD8(+) T cells. Nat Immunol. 2025;26(1):92\u2013104.","journal-title":"Nat Immunol"},{"issue":"1","key":"4251_CR31","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1007\/s00018-023-05098-8","volume":"81","author":"N Ebrahimi","year":"2024","unstructured":"Ebrahimi N, Abdulwahid ARR, Mansouri A, Karimi N, Bostani RJ, Beiranvand S, et al. Targeting the NF-kappaB pathway as a potential regulator of immune checkpoints in cancer immunotherapy. Cell Mol Life Sci. 2024;81(1):106.","journal-title":"Cell Mol Life Sci"},{"issue":"4","key":"4251_CR32","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.ccell.2025.03.006","volume":"43","author":"SL Wang","year":"2025","unstructured":"Wang SL, Chan TA. Navigating established and emerging biomarkers for immune checkpoint inhibitor therapy. Cancer Cell. 2025;43(4):641\u201364.","journal-title":"Cancer Cell"},{"issue":"11","key":"4251_CR33","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.1038\/s41590-024-01992-w","volume":"25","author":"DH Shu","year":"2024","unstructured":"Shu DH, Ho WJ, Kagohara LT, Girgis A, Shin SM, Danilova L, et al. Immunotherapy response induces divergent tertiary lymphoid structure morphologies in hepatocellular carcinoma. Nat Immunol. 2024;25(11):2110\u201323.","journal-title":"Nat Immunol"},{"issue":"1","key":"4251_CR34","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s00018-025-05642-8","volume":"82","author":"FI Espinoza","year":"2025","unstructured":"Espinoza FI, Tankov S, Chliate S, Pereira Couto J, Marinari E, Vermeil T, et al. Targeting HIF-2alpha in glioblastoma reshapes the immune infiltrate and enhances response to immune checkpoint blockade. Cell Mol Life Sci. 2025;82(1):119.","journal-title":"Cell Mol Life Sci"},{"issue":"12","key":"4251_CR35","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.1038\/s41590-024-02014-5","volume":"25","author":"AC Guanizo","year":"2024","unstructured":"Guanizo AC, Luong Q, Jayasekara WSN, de Geus ED, Inampudi C, Xue VS, et al. A STAT3-STING-IFN axis controls the metastatic spread of small cell lung cancer. Nat Immunol. 2024;25(12):2259\u201369.","journal-title":"Nat Immunol"},{"issue":"10","key":"4251_CR36","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1038\/s41590-024-01932-8","volume":"25","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Naderi Yeganeh P, Zhang H, Wang SY, Li Z, Gu B, et al. Tumor editing suppresses innate and adaptive antitumor immunity and is reversed by inhibiting DNA methylation. Nat Immunol. 2024;25(10):1858\u201370.","journal-title":"Nat Immunol"},{"issue":"1","key":"4251_CR37","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/s41590-023-01687-8","volume":"25","author":"A Lei","year":"2024","unstructured":"Lei A, Yu H, Lu S, Lu H, Ding X, Tan T, et al. A second-generation M1-polarized CAR macrophage with antitumor efficacy. Nat Immunol. 2024;25(1):102\u201316.","journal-title":"Nat Immunol"},{"issue":"1","key":"4251_CR38","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s00018-025-05649-1","volume":"82","author":"SY Lee","year":"2025","unstructured":"Lee SY, Prieto-Fernandez E, Egia-Mendikute L, Antonana-Vildosola A, Velasco-Beltran P, Bosch A, et al. Syndecan-3 positively regulates the pro-inflammatory function of macrophages. Cell Mol Life Sci. 2025;82(1):145.","journal-title":"Cell Mol Life Sci"},{"issue":"7769","key":"4251_CR39","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/s41586-019-1456-0","volume":"572","author":"AA Barkal","year":"2019","unstructured":"Barkal AA, Brewer RE, Markovic M, Kowarsky M, Barkal SA, Zaro BW, et al. CD24 signalling through macrophage Siglec-10 is a target for cancer immunotherapy. Nature. 2019;572(7769):392\u20136.","journal-title":"Nature"},{"issue":"7655","key":"4251_CR40","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/nature22396","volume":"545","author":"SR Gordon","year":"2017","unstructured":"Gordon SR, Maute RL, Dulken BW, Hutter G, George BM, McCracken MN, et al. PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity. Nature. 2017;545(7655):495\u20139.","journal-title":"Nature"},{"issue":"5","key":"4251_CR41","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1002\/hep.510230542","volume":"23","author":"LG Bayon","year":"1996","unstructured":"Bayon LG, Izquierdo MA, Sirovich I, van Rooijen N, Beelen RH, Meijer S. Role of Kupffer cells in arresting circulating tumor cells and controlling metastatic growth in the liver. Hepatology. 1996;23(5):1224\u201331.","journal-title":"Hepatology"},{"issue":"6","key":"4251_CR42","doi-asserted-by":"publisher","first-page":"2303","DOI":"10.3892\/ijo.2014.2662","volume":"45","author":"H Matsumura","year":"2014","unstructured":"Matsumura H, Kondo T, Ogawa K, Tamura T, Fukunaga K, Murata S, et al. Kupffer cells decrease metastasis of colon cancer cells to the liver in the early stage. Int J Oncol. 2014;45(6):2303\u201310.","journal-title":"Int J Oncol"},{"issue":"6","key":"4251_CR43","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1097\/SLA.0b013e3181b0ebf8","volume":"250","author":"CH Hsieh","year":"2009","unstructured":"Hsieh CH, Nickel EA, Hsu JT, Schwacha MG, Bland KI, Chaudry IH. Trauma-hemorrhage and hypoxia differentially influence kupffer cell phagocytic capacity: role of hypoxia-inducible-factor-1alpha and phosphoinositide 3-kinase\/Akt activation. Ann Surg. 2009;250(6):995\u20131001.","journal-title":"Ann Surg"},{"issue":"5","key":"4251_CR44","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1016\/j.cell.2015.11.011","volume":"163","author":"KE Lee","year":"2015","unstructured":"Lee KE, Simon MC, SnapShot. Hypoxia-Inducible Factors. Cell. 2015;163(5):1288\u2013e1.","journal-title":"Cell"},{"issue":"1","key":"4251_CR45","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1007\/s00018-024-05388-9","volume":"81","author":"Y Huang","year":"2024","unstructured":"Huang Y, Yang Y, Chen X, Zeng S, Chen Y, Wang H, et al. Downregulation of malic enzyme 3 facilitates progression of gastric carcinoma via regulating intracellular oxidative stress and hypoxia-inducible factor-1alpha stabilization. Cell Mol Life Sci. 2024;81(1):375.","journal-title":"Cell Mol Life Sci"},{"issue":"12","key":"4251_CR46","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1038\/s41590-023-01671-2","volume":"24","author":"Z Tang","year":"2023","unstructured":"Tang Z, Zhong MC, Qian J, Galindo CC, Davidson D, Li J, et al. CD47 masks pro-phagocytic ligands in cis on tumor cells to suppress antitumor immunity. Nat Immunol. 2023;24(12):2032\u201341.","journal-title":"Nat Immunol"},{"issue":"18","key":"4251_CR47","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1056\/NEJMoa1807315","volume":"379","author":"R Advani","year":"2018","unstructured":"Advani R, Flinn I, Popplewell L, Forero A, Bartlett NL, Ghosh N, et al. CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin\u2019s Lymphoma. N Engl J Med. 2018;379(18):1711\u201321.","journal-title":"N Engl J Med"},{"issue":"12","key":"4251_CR48","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1200\/JCO.18.02018","volume":"37","author":"BI Sikic","year":"2019","unstructured":"Sikic BI, Lakhani N, Patnaik A, Shah SA, Chandana SR, Rasco D, et al. First-in-Human, First-in-Class Phase I Trial of the Anti-CD47 Antibody Hu5F9-G4 in Patients With Advanced Cancers. J Clin Oncol. 2019;37(12):946\u201353.","journal-title":"J Clin Oncol"},{"issue":"5","key":"4251_CR49","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/j.ccr.2014.03.010","volume":"25","author":"JH Yuan","year":"2014","unstructured":"Yuan JH, Yang F, Wang F, Ma JZ, Guo YJ, Tao QF, et al. A long noncoding RNA activated by TGF-beta promotes the invasion-metastasis cascade in hepatocellular carcinoma. Cancer Cell. 2014;25(5):666\u201381.","journal-title":"Cancer Cell"},{"issue":"20","key":"4251_CR50","doi-asserted-by":"publisher","first-page":"3739","DOI":"10.1111\/febs.13839","volume":"283","author":"XT Zhu","year":"2016","unstructured":"Zhu XT, Yuan JH, Zhu TT, Li YY, Cheng XY. Long noncoding RNA glypican 3 (GPC3) antisense transcript 1 promotes hepatocellular carcinoma progression via epigenetically activating GPC3. FEBS J. 2016;283(20):3739\u201354.","journal-title":"FEBS J"},{"issue":"7","key":"4251_CR51","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1038\/ncb3538","volume":"19","author":"JH Yuan","year":"2017","unstructured":"Yuan JH, Liu XN, Wang TT, Pan W, Tao QF, Zhou WP, et al. The MBNL3 splicing factor promotes hepatocellular carcinoma by increasing PXN expression through the alternative splicing of lncRNA-PXN-AS1. Nat Cell Biol. 2017;19(7):820\u201332.","journal-title":"Nat Cell Biol"},{"issue":"1","key":"4251_CR52","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s11658-022-00342-8","volume":"27","author":"YZ Dai","year":"2022","unstructured":"Dai YZ, Liu YD, Li J, Chen MT, Huang M, Wang F, et al. METTL16 promotes hepatocellular carcinoma progression through downregulating RAB11B-AS1 in an m(6)A-dependent manner. Cell Mol Biol Lett. 2022;27(1):41.","journal-title":"Cell Mol Biol Lett"},{"issue":"2","key":"4251_CR53","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/s41419-020-2338-y","volume":"11","author":"S Mo","year":"2020","unstructured":"Mo S, Zhang L, Dai W, Han L, Wang R, Xiang W, et al. Antisense lncRNA LDLRAD4-AS1 promotes metastasis by decreasing the expression of LDLRAD4 and predicts a poor prognosis in colorectal cancer. Cell Death Dis. 2020;11(2):155.","journal-title":"Cell Death Dis"},{"issue":"1","key":"4251_CR54","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s12943-017-0681-0","volume":"16","author":"JK Li","year":"2017","unstructured":"Li JK, Chen C, Liu JY, Shi JZ, Liu SP, Liu B, et al. Long noncoding RNA MRCCAT1 promotes metastasis of clear cell renal cell carcinoma via inhibiting NPR3 and activating p38-MAPK signaling. Mol Cancer. 2017;16(1):111.","journal-title":"Mol Cancer"},{"issue":"1","key":"4251_CR55","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1101\/gad.270959.115","volume":"30","author":"G Arun","year":"2016","unstructured":"Arun G, Diermeier S, Akerman M, Chang KC, Wilkinson JE, Hearn S, et al. Differentiation of mammary tumors and reduction in metastasis upon Malat1 lncRNA loss. Genes Dev. 2016;30(1):34\u201351.","journal-title":"Genes Dev"},{"issue":"8","key":"4251_CR56","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/s41573-021-00219-z","volume":"20","author":"M Winkle","year":"2021","unstructured":"Winkle M, El-Daly SM, Fabbri M, Calin GA. Noncoding RNA therapeutics - challenges and potential solutions. Nat Rev Drug Discov. 2021;20(8):629\u201351.","journal-title":"Nat Rev Drug Discov"},{"issue":"5","key":"4251_CR57","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1016\/j.ymthe.2017.03.023","volume":"25","author":"CA Stein","year":"2017","unstructured":"Stein CA, Castanotto D. FDA-Approved Oligonucleotide Therapies in 2017. Mol Ther. 2017;25(5):1069\u201375.","journal-title":"Mol Ther"},{"issue":"6","key":"4251_CR58","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1038\/s41565-021-00898-0","volume":"16","author":"JA Kulkarni","year":"2021","unstructured":"Kulkarni JA, Witzigmann D, Thomson SB, Chen S, Leavitt BR, Cullis PR, et al. The current landscape of nucleic acid therapeutics. Nat Nanotechnol. 2021;16(6):630\u201343.","journal-title":"Nat Nanotechnol"}],"container-title":["Cancer Cell International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12935-026-04251-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-026-04251-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-026-04251-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T08:05:05Z","timestamp":1776326705000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12935-026-04251-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,9]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4251"],"URL":"https:\/\/doi.org\/10.1186\/s12935-026-04251-0","relation":{},"ISSN":["1475-2867"],"issn-type":[{"value":"1475-2867","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,9]]},"assertion":[{"value":"21 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Affiliated Hospital of Youjiang Medical University for Nationalities Institutional Review Board (approval no. YYFY-LL-2023-127), with all participants providing written consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"168"}}